AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 94 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $176,000 | +10.7% | 22,408 | 0.0% | 0.05% | +4.5% |
| Q3 2020 | $159,000 | -23.2% | 22,408 | 0.0% | 0.04% | -22.8% |
| Q2 2020 | $207,000 | +99.0% | 22,408 | 0.0% | 0.06% | +62.9% |
| Q1 2020 | $104,000 | -39.2% | 22,408 | 0.0% | 0.04% | -5.4% |
| Q4 2019 | $171,000 | -0.6% | 22,408 | 0.0% | 0.04% | -5.1% |
| Q3 2019 | $172,000 | +12.4% | 22,408 | 0.0% | 0.04% | +11.4% |
| Q2 2019 | $153,000 | -15.0% | 22,408 | 0.0% | 0.04% | -16.7% |
| Q1 2019 | $180,000 | +7.1% | 22,408 | 0.0% | 0.04% | -6.7% |
| Q4 2018 | $168,000 | -21.5% | 22,408 | 0.0% | 0.04% | -15.1% |
| Q3 2018 | $214,000 | -9.7% | 22,408 | 0.0% | 0.05% | -5.4% |
| Q2 2018 | $237,000 | +6.8% | 22,408 | 0.0% | 0.06% | 0.0% |
| Q1 2018 | $222,000 | +83.5% | 22,408 | 0.0% | 0.06% | +60.0% |
| Q4 2017 | $121,000 | +10.0% | 22,408 | 0.0% | 0.04% | 0.0% |
| Q3 2017 | $110,000 | +27.9% | 22,408 | 0.0% | 0.04% | +9.4% |
| Q2 2017 | $86,000 | -48.5% | 22,408 | 0.0% | 0.03% | -52.2% |
| Q1 2017 | $167,000 | +72.2% | 22,408 | 0.0% | 0.07% | +24.1% |
| Q4 2016 | $97,000 | – | 22,408 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $532,000 | 6.17% |
| Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
| GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
| Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
| Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
| Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
| Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
| Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |